BeOne Medicines
ONC
#647
Rank
ยฃ27.10 B
Marketcap
ยฃ244.91
Share price
1.11%
Change (1 day)
50.39%
Change (1 year)
BeOne Medicines formerly known as BeiGene, is a multinational pharmaceutical company engaged in the R&D, commercialization of molecularly-targeted, and immuno-oncology drugs for the treatment of cancer.

BeOne Medicines (ONC) - Total debt

Total debt on the balance sheet as of September 2025 : ยฃ0.76 Billion

According to BeOne Medicines's latest financial reports the company's total debt is ยฃ0.76 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

BeOne Medicines - Total debt on balance sheet (from 2014 to 2025)

Total debt by year

Year Total debt Change
2024-12-31ยฃ0.86 B17.86%
2023-12-31ยฃ0.73 B48.04%
2022-12-31ยฃ0.49 B-4.16%
2021-12-31ยฃ0.51 B24.82%
2020-12-31ยฃ0.41 B94.93%
2019-12-31ยฃ0.21 B35.32%
2018-12-31ยฃ0.15 B28.25%
2017-12-31ยฃ0.12 B770.07%
2016-12-31ยฃ14 M-0.13%
2015-12-31ยฃ14.02 M57.81%
2014-12-31ยฃ8.88 M-46.42%
2013-12-31ยฃ16.58 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Onconova Therapeutics
ONTX
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
OPKO Health
OPK
ยฃ0.29 B-61.23%๐Ÿ‡บ๐Ÿ‡ธ USA